SCHEMBL5034786

SCHEMBL5034786

CON(C)C(=O)c1csc(N(C(=O)c2ccc(Cl)cc2Cl)c2ccc(Cl)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.44
KDM4E B2RXH2 1/20 0.36
PTGER1 P34995 1/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 1/20 0.35
RAB9A P51151 3/20 0.35
NPC1 O15118 2/20 0.35
ATM Q13315 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
ALDH1A1 P00352 2/20 0.34
FLT1 P17948 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
GRM1 Q13255 1/20 0.34
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5032643 0.90 FLT1 (0.38) CYP3A4MAPTKMT2ARAB9ANPC1
SCHEMBL5038951 0.90 KDM4E (0.43) CYP3A4KDM4EMAPTRAB9ANPC1
SCHEMBL5034860 0.89 CYP3A4 (0.47) CYP3A4KDM4EPTGER1MAPTKMT2A
SCHEMBL5032541 0.85 CYP3A4 (0.52) CYP3A4KDM4EPTGER1MAPTKMT2A
SCHEMBL5035304 0.85 CYP3A4 (0.54) CYP3A4KDM4EMAPTKMT2ARAB9A
SCHEMBL5032585 0.85 CYP3A4 (0.44) CYP3A4KDM4EKMT2AALDH1A1
SCHEMBL5034952 0.85 CYP3A4 (0.46) CYP3A4KDM4EPTGER1KMT2ARAB9A
SCHEMBL14190164 0.84 CYP3A4 (0.45) CYP3A4KDM4EPTGER1MAPTKMT2A
SCHEMBL5034751 0.84 CYP3A4 (0.47) CYP3A4KDM4EPTGER1KMT2ARAB9A
SCHEMBL5034868 0.84 CYP3A4 (0.45) CYP3A4KDM4EMAPTKMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US claimed
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP claimed
JP-2007513193-A 2007-05-24 JP claimed
EP-1694673-A1 NOVEL THIAZOLE DERIVATES F.HOFFMANN-LA ROCHE AG (CH) 2006-08-30 EP claimed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US claimed
WO-2005058887-A1 NOVEL THIAZOLE DERIVATES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO claimed
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP disclosed
EP-1694673-A1 NOVEL THIAZOLE DERIVATES F.HOFFMANN-LA ROCHE AG (CH) 2006-08-30 EP disclosed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed
WO-2005058887-A1 NOVEL THIAZOLE DERIVATES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 CYP3A4 693/4885KDM4E 3200/4885PTGER1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.